Clinical Trials List
Protocol Number201902287A3A0
2020-11-01 - 2022-10-31
Phase IV
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yu-Tung Wu Division of General Surgery
- 許致博 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
140 participants
-
Global
140 participants
